Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants

Leo M. Stolk*, Frank de Vries, Chiel Ebbelaar, Anthonius de Boer, Tom Schalekamp, Patrick Souverein, Arina ten Cate-Hoek, Andrea M. Burden

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1835-1843
Number of pages9
JournalBritish Journal of Clinical Pharmacology
Volume83
Issue number8
DOIs
Publication statusPublished - Aug 2017

Keywords

  • anticoagulants
  • cardiovascular pharmacology
  • pharmacoepidemiology
  • RANDOMIZED-CONTROLLED-TRIALS
  • INTERVENTIONAL TRIALS
  • NATIONWIDE COHORT
  • WARFARIN
  • DABIGATRAN
  • METAANALYSIS
  • SAFETY
  • EFFICACY
  • STROKE
  • ASSOCIATION

Cite this